Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Steurer

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemiaIrina Gryshchenko, Sebastian Hofbauer, Markus Stoecher, et al.
European Journal of Haematology|April 3, 2016
Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemiaVeronika Buxhofer-Ausch, Michael Steurer, Siegfried Sormann, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2005
Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patientsDominik Wolf, Holger Rumpold, Christian Koppelstätter, et al.
Anticancer Research|August 9, 2015
Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: An Observational StudyMarijana Ninkovic, Michael Fiegl, Michael Mian, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 6, 2011
Feasibility and toxicity of concomitant radio/immunotherapy with MabThera (Rituximab®) for patients with non-Hodkin's Lymphoma: results of a prospective phase I/II studyAlfred Haidenberger, Sabine Fromm-Haidenberger, Alexander de Vries, et al.
European Journal of Cancer Care|August 30, 2019
Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient-reported outcome assessment for the Austrian Myelome RegistryMonika Sztankay, Lucia Neppl, Lisa M Wintner, et al.
Clinical Neuropathology|November 14, 2013
Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literatureMarkus Hutterer, Michael Steurer, Romana Höftberger, et al.
Plos One|February 14, 2015
Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivoHannes Neuwirt, Elisabeth Wabnig, Clemens Feistritzer, et al.
Cancer|November 15, 2006
Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasiaKathrin Strasser-Weippl, Michael Steurer, Mathias Kees, et al.
Leukemia & Lymphoma|January 7, 2006
Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic scoreKathrin Strasser-Weippl, Michael Steurer, Mathias Kees, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemiaIrina Gryshchenko, Sebastian Hofbauer, Markus Stoecher, et al.
European Journal of Haematology|April 3, 2016
Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemiaVeronika Buxhofer-Ausch, Michael Steurer, Siegfried Sormann, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2005
Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patientsDominik Wolf, Holger Rumpold, Christian Koppelstätter, et al.
Anticancer Research|August 9, 2015
Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: An Observational StudyMarijana Ninkovic, Michael Fiegl, Michael Mian, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 6, 2011
Feasibility and toxicity of concomitant radio/immunotherapy with MabThera (Rituximab®) for patients with non-Hodkin's Lymphoma: results of a prospective phase I/II studyAlfred Haidenberger, Sabine Fromm-Haidenberger, Alexander de Vries, et al.
European Journal of Cancer Care|August 30, 2019
Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient-reported outcome assessment for the Austrian Myelome RegistryMonika Sztankay, Lucia Neppl, Lisa M Wintner, et al.
Clinical Neuropathology|November 14, 2013
Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literatureMarkus Hutterer, Michael Steurer, Romana Höftberger, et al.
Plos One|February 14, 2015
Akacid medical formulation induces apoptosis in myeloid and lymphatic leukemic cell lines in vitro and in vivoHannes Neuwirt, Elisabeth Wabnig, Clemens Feistritzer, et al.
Cancer|November 15, 2006
Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasiaKathrin Strasser-Weippl, Michael Steurer, Mathias Kees, et al.
Leukemia & Lymphoma|January 7, 2006
Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic scoreKathrin Strasser-Weippl, Michael Steurer, Mathias Kees, et al.
Pageof 8